-
Je něco špatně v tomto záznamu ?
Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer Agents
AS. Rudovich, M. Peřina, AV. Krech, MY. Novozhilova, AM. Tumilovich, TV. Shkel, IP. Grabovec, M. Kvasnica, L. Mada, MG. Zavialova, AR. Mekhtiev, R. Jorda, VN. Zhabinskii, VA. Khripach
Jazyk angličtina Země Švýcarsko
Typ dokumentu časopisecké články
NLK
Free Medical Journals
od 2000
Freely Accessible Science Journals
od 2000
PubMed Central
od 2007
Europe PubMed Central
od 2007
ProQuest Central
od 2000-03-01
Open Access Digital Library
od 2000-01-01
Open Access Digital Library
od 2007-01-01
Health & Medicine (ProQuest)
od 2000-03-01
ROAD: Directory of Open Access Scholarly Resources
od 2000
PubMed
36362320
DOI
10.3390/ijms232113534
Knihovny.cz E-zdroje
- MeSH
- androgenní receptory metabolismus MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nádory prostaty * farmakoterapie metabolismus MeSH
- protinádorové látky * chemie MeSH
- simulace molekulového dockingu MeSH
- steroid-17-alfa-hydroxylasa metabolismus MeSH
- steroidy farmakologie terapeutické užití MeSH
- Check Tag
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
Steroids with a nitrogen-containing heterocycle in the side chain are known as effective inhibitors of androgen signaling and/or testosterone biosynthesis, thus showing beneficial effects for the treatment of prostate cancer. In this work, a series of 3β-hydroxy-5-ene steroids, containing an isoxazole fragment in their side chain, was synthesized. The key steps included the preparation of Weinreb amide, its conversion to acetylenic ketones, and the 1,2- or 1,4-addition of hydroxylamine, depending on the solvent used. The biological activity of the obtained compounds was studied in a number of tests, including their effects on 17α-hydroxylase and 17,20-lyase activity of human CYP17A1 and the ability of selected compounds to affect the downstream androgen receptor signaling. Three derivatives diminished the transcriptional activity of androgen receptor and displayed reasonable antiproliferative activity. The candidate compound, 24j (17R)-17-((3-(2-hydroxypropan-2-yl)isoxazol-5-yl)methyl)-androst-5-en-3β-ol, suppressed the androgen receptor signaling and decreased its protein level in two prostate cancer cell lines, LNCaP and LAPC-4. Interaction of compounds with CYP17A1 and the androgen receptor was confirmed and described by molecular docking.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22032730
- 003
- CZ-PrNML
- 005
- 20230131150749.0
- 007
- ta
- 008
- 230120s2022 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/ijms232113534 $2 doi
- 035 __
- $a (PubMed)36362320
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Rudovich, Anton S $u Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Kuprevich Str., 5/2, 220141 Minsk, Belarus $1 https://orcid.org/000000033521727X
- 245 10
- $a Synthesis and Biological Evaluation of New Isoxazolyl Steroids as Anti-Prostate Cancer Agents / $c AS. Rudovich, M. Peřina, AV. Krech, MY. Novozhilova, AM. Tumilovich, TV. Shkel, IP. Grabovec, M. Kvasnica, L. Mada, MG. Zavialova, AR. Mekhtiev, R. Jorda, VN. Zhabinskii, VA. Khripach
- 520 9_
- $a Steroids with a nitrogen-containing heterocycle in the side chain are known as effective inhibitors of androgen signaling and/or testosterone biosynthesis, thus showing beneficial effects for the treatment of prostate cancer. In this work, a series of 3β-hydroxy-5-ene steroids, containing an isoxazole fragment in their side chain, was synthesized. The key steps included the preparation of Weinreb amide, its conversion to acetylenic ketones, and the 1,2- or 1,4-addition of hydroxylamine, depending on the solvent used. The biological activity of the obtained compounds was studied in a number of tests, including their effects on 17α-hydroxylase and 17,20-lyase activity of human CYP17A1 and the ability of selected compounds to affect the downstream androgen receptor signaling. Three derivatives diminished the transcriptional activity of androgen receptor and displayed reasonable antiproliferative activity. The candidate compound, 24j (17R)-17-((3-(2-hydroxypropan-2-yl)isoxazol-5-yl)methyl)-androst-5-en-3β-ol, suppressed the androgen receptor signaling and decreased its protein level in two prostate cancer cell lines, LNCaP and LAPC-4. Interaction of compounds with CYP17A1 and the androgen receptor was confirmed and described by molecular docking.
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a androgenní receptory $x metabolismus $7 D011944
- 650 _2
- $a simulace molekulového dockingu $7 D062105
- 650 _2
- $a steroid-17-alfa-hydroxylasa $x metabolismus $7 D013254
- 650 12
- $a protinádorové látky $x chemie $7 D000970
- 650 12
- $a nádory prostaty $x farmakoterapie $x metabolismus $7 D011471
- 650 _2
- $a steroidy $x farmakologie $x terapeutické užití $7 D013256
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Peřina, Miroslav $u Department of Experimental Biology, Faculty of Science, Palacký University Olomouc, Šlechtitelů 27, 78371 Olomouc, Czech Republic
- 700 1_
- $a Krech, Anastasiya V $u Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Kuprevich Str., 5/2, 220141 Minsk, Belarus
- 700 1_
- $a Novozhilova, Maria Y $u Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Kuprevich Str., 5/2, 220141 Minsk, Belarus
- 700 1_
- $a Tumilovich, Anastasia M $u Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Kuprevich Str., 5/2, 220141 Minsk, Belarus
- 700 1_
- $a Shkel, Tatyana V $u Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Kuprevich Str., 5/2, 220141 Minsk, Belarus
- 700 1_
- $a Grabovec, Irina P $u Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Kuprevich Str., 5/2, 220141 Minsk, Belarus
- 700 1_
- $a Kvasnica, Miroslav $u Department of Experimental Biology, Faculty of Science, Palacký University Olomouc, Šlechtitelů 27, 78371 Olomouc, Czech Republic $1 https://orcid.org/0000000205973261
- 700 1_
- $a Mada, Lukáš $u Department of Experimental Biology, Faculty of Science, Palacký University Olomouc, Šlechtitelů 27, 78371 Olomouc, Czech Republic $1 https://orcid.org/0000000226100515
- 700 1_
- $a Zavialova, Maria G $u Institute of Biomedical Chemistry, 10 Building 8, Pogodinskaya Str., 119121 Moscow, Russia $1 https://orcid.org/0000000307612299
- 700 1_
- $a Mekhtiev, Arif R $u Institute of Biomedical Chemistry, 10 Building 8, Pogodinskaya Str., 119121 Moscow, Russia
- 700 1_
- $a Jorda, Radek $u Department of Experimental Biology, Faculty of Science, Palacký University Olomouc, Šlechtitelů 27, 78371 Olomouc, Czech Republic $u Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University Olomouc, Hněvotínská 5, 77900 Olomouc, Czech Republic $1 https://orcid.org/0000000249057126
- 700 1_
- $a Zhabinskii, Vladimir N $u Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Kuprevich Str., 5/2, 220141 Minsk, Belarus $1 https://orcid.org/0000000185912794
- 700 1_
- $a Khripach, Vladimir A $u Institute of Bioorganic Chemistry, National Academy of Sciences of Belarus, Kuprevich Str., 5/2, 220141 Minsk, Belarus $1 https://orcid.org/0000000238509860
- 773 0_
- $w MED00176142 $t International journal of molecular sciences $x 1422-0067 $g Roč. 23, č. 21 (2022)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36362320 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230120 $b ABA008
- 991 __
- $a 20230131150745 $b ABA008
- 999 __
- $a ok $b bmc $g 1891458 $s 1184065
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2022 $b 23 $c 21 $e 20221104 $i 1422-0067 $m International journal of molecular sciences $n Int J Mol Sci $x MED00176142
- LZP __
- $a Pubmed-20230120